Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -1.07% is 95% above its 5-year average of -20.21%, near the high end of its 5-year range (-38.42%–-1.07%).
As of the fiscal period ended Tuesday, June 30, 2026. 80.18% above its 12-month average of -5.40%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -1.07%.
RETURN ON INVESTED CAPITAL (ROIC)
-1.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-5.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-13.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-20.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-22.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+80.18%
CURRENT VS 3Y AVG
+92.06%
CURRENT VS 5Y AVG
+94.70%
CURRENT VS 10Y AVG
+95.14%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 652 covered companies
CURRENT VS SECTOR MEDIAN
+96.81%
vs the sector median at left
iRhythm Technologies, Inc.
Market Cap
$3.52B
Return on Invested Capital (ROIC)
-1.07%
TTM Avg
-5.40%
3Y Avg
-13.49%
5Y Avg
-20.21%
Market Cap
$3.55B
Return on Invested Capital (ROIC)
-28.15%
TTM Avg
-46.92%
3Y Avg
-38.64%
5Y Avg
-44.96%
Market Cap
$3.56B
Return on Invested Capital (ROIC)
-17.68%
TTM Avg
-22.74%
3Y Avg
-21.16%
5Y Avg
-18.86%
Market Cap
$3.44B
Return on Invested Capital (ROIC)
6.25%
TTM Avg
16.80%
3Y Avg
-7.33%
5Y Avg
-16.60%
Market Cap
$3.41B
Return on Invested Capital (ROIC)
-0.93%
TTM Avg
1.17%
3Y Avg
-16.63%
5Y Avg
-13.35%
Market Cap
$3.40B
Return on Invested Capital (ROIC)
-79.40%
TTM Avg
-65.84%
3Y Avg
-73.62%
5Y Avg
-96.54%
Market Cap
$3.39B
Return on Invested Capital (ROIC)
-409.85%
TTM Avg
-257.76%
3Y Avg
-257.76%
5Y Avg
-257.76%
Market Cap
$3.12B
Return on Invested Capital (ROIC)
-50.82%
TTM Avg
-45.69%
3Y Avg
-35.19%
5Y Avg
-27.59%
Market Cap
$3.10B
Return on Invested Capital (ROIC)
-66.60%
TTM Avg
-119.97%
3Y Avg
-72.56%
5Y Avg
-159.91%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iRhythm Technologies, Inc. (IRTC) | $3.52B | -1.07% | -5.40% | -13.49% | -20.21% |
| Celcuity Inc. (CELC)vs › | $3.55B | -28.15% | -46.92% | -38.64% | -44.96% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.56B | -17.68% | -22.74% | -21.16% | -18.86% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.44B | 6.25% | 16.80% | -7.33% | -16.60% |
| CareDx, Inc (CDNA)vs › | $3.41B | -0.93% | 1.17% | -16.63% | -13.35% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.40B | -79.40% | -65.84% | -73.62% | -96.54% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.39B | -409.85% | -257.76% | -257.76% | -257.76% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.12B | -50.82% | -45.69% | -35.19% | -27.59% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.10B | -66.60% | -119.97% | -72.56% | -159.91% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.09B | 9.95% | -25.98% | -51.77% | -51.95% |
ROIC
-1.1%
ROE
-7.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -1.07% |
| 2026-03-31 | -2.47% |
| 2025-12-31 | -4.84% |
| 2025-09-30 | -6.47% |
| 2025-06-30 | -12.16% |
| 2025-03-31 | -13.46% |
| 2024-12-31 | -14.08% |
| 2024-09-30 | -18.60% |
| 2024-06-30 | -15.29% |
| 2024-03-31 | -14.95% |
| 2023-12-31 | -38.42% |
| 2023-09-30 | -30.26% |
| 2023-06-30 | -28.28% |
| 2023-03-31 | -30.82% |
| 2022-12-31 | -31.68% |
| 2022-09-30 | -35.11% |
| 2022-06-30 | -34.90% |
| 2022-03-31 | -32.98% |
| 2021-12-31 | -25.84% |
| 2021-09-30 | -18.90% |
| 2021-06-30 | -13.87% |
| 2021-03-31 | -14.39% |
| 2020-12-31 | -9.54% |
| 2020-09-30 | -11.26% |
| 2020-06-30 | -26.68% |
| 2020-03-31 | -22.02% |
| 2019-12-31 | -21.38% |
| 2019-09-30 | -18.26% |
| 2019-06-30 | -23.04% |
| 2019-03-31 | -45.87% |
| 2018-12-31 | -48.16% |
| 2018-09-30 | -43.59% |
| 2018-06-30 | -38.44% |
| 2018-03-31 | -31.03% |
| 2017-12-31 | -23.99% |
| 2017-09-30 | -17.63% |
| 2017-06-30 | -14.65% |
| 2017-03-31 | -12.66% |
| 2016-12-31 | -12.47% |
| 2016-09-30 | -100.40% |
| 2016-06-30 | -101.29% |
| 2015-12-31 | -74.34% |
| 2015-09-30 | -153.14% |
